3THC image
Entry Detail
PDB ID:
3THC
Keywords:
Title:
Crystal structure of human beta-galactosidase in complex with galactose
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2011-08-18
Release Date:
2011-12-07
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Beta-galactosidase
Chain IDs:A, B, C, D
Chain Length:654
Number of Molecules:4
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN C ASN GLYCOSYLATION SITE
Primary Citation
Crystal structure of human beta-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases
J.Biol.Chem. 287 1801 1812 (2012)
PMID: 22128166 DOI: 10.1074/jbc.M111.293795

Abstact

G(M1) gangliosidosis and Morquio B are autosomal recessive lysosomal storage diseases associated with a neurodegenerative disorder or dwarfism and skeletal abnormalities, respectively. These diseases are caused by deficiencies in the lysosomal enzyme β-d-galactosidase (β-Gal), which lead to accumulations of the β-Gal substrates, G(M1) ganglioside, and keratan sulfate. β-Gal is an exoglycosidase that catalyzes the hydrolysis of terminal β-linked galactose residues. This study shows the crystal structures of human β-Gal in complex with its catalytic product galactose or with its inhibitor 1-deoxygalactonojirimycin. Human β-Gal is composed of a catalytic TIM barrel domain followed by β-domain 1 and β-domain 2. To gain structural insight into the molecular defects of β-Gal in the above diseases, the disease-causing mutations were mapped onto the three-dimensional structure. Finally, the possible causes of the diseases are discussed.

Legend

Protein

Chemical

Disease

Primary Citation of related structures